ANTIARRHYTHMIC EFFICACY OF SODIUM VALPROA TE

The antiarrhythmic efficacy of the anticonvulsant sodium valproate was studied in 22 patients with ventricular premature contraction in the immediate (10-15 days) and late (2-5 months) periods of therapy. The p rolong antiarrhythmic effect of the drug was observed in 66 % of the p atients in whom it was beneficial in the first days of therapy. The re sults obtained provide strong evidence for the efficacy of sodium valp roate in patients with ventricular premature contraction occurring in the presence of neurocirculatory dystonia.